Roche accuses competitor of infringing diabetes patent
22-06-2020
Fed Circuit restores two Illumina DNA patents in blow to Roche
19-03-2020
Genentech in $1.7bn immuno-oncology deal
27-02-2020
Testing / Shutterstock.com
Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Roche, Innovent Biologics, collaboration, research and development, cancer, Michael Yu, CAR-T, biotech
